June 4, 2021 - 10:00 to 15:30
The second Swiss Genomics Forum I #SGF21 I organized by the Health 2030 Genome Center will be held online. It will bring together researchers, clinicians, patient communities, and other stakeholder groups to meet and discuss the future of genomics.
The following themes will be explored at the SGF2021:
- Genomics: opportunities and challenges
- Diseases: latest genomics-based diagnostic and therapeutic approaches
- Personalized Health: relevance and impact of genomic medicine
- Data: legal and ethical issues around sharing patient data
- Collaboration: strategic partnerships
Background of the event:
Genomic analysis is at the forefront of research and clinical developments around the world. Leading countries in research including the USA and the UK have made substantial public and private investments in developing sequencing capacity and the necessary data analysis tools for research and clinical use.
Existing genome centers with ambitious projects have offered exceptional resources to the research and clinical communities and have led efforts to integrate genome sequencing in clinical practice.
As genome analysis becomes commonplace in research and clinics, Switzerland has much to offer in terms of scientific strength, quality of its healthcare system (including universal coverage), and detailed patient phenotyping.
In participating in our event, you will be granted 6 credits from the Swiss Society of Medical Genetics. For students, 1 ECTS with a poster/flash talk or 0.5 ECTS without.
10:00 – 10:15 Swiss Genomics Forum Opening – Welcome Address
10:15 – 12:00 Invited keynote speakers
- Emma Hodcroft, University of Bern, Institute of Social and Preventive Medicine, CH. "Practical Phylogenetics for Public Health: Realising research in real-time"
- Michael Inouye, University of Cambridge, UK "Polygenic scores: Potential for clinical utility and target identification"
- Effy Vayena and Kelly Ormond, ETH Zürich, CH "Returning genomic results to research participants and patients: recent policy developments"
12:00 – 13:00 Lunch break
13:00 – 14:30 Invited keynote speakers
- Samuli Ripatti, University of Helsinki, Institute for Molecular Medicine Finland "The role of genome in primary prevention of common diseases"
- Tuuli Lappalainen, Columbia University Department of Systems Biology, New York, USA. "Functional variation in the human genome: lessons from the transcriptome"
- Nicholas Katsanis, Rescindo Therapeutics Inc, USA "The genetics of drug discovery in the post-genome era"
14:30 – 15:30 Panel discussion: Opportunities in clinical genomic. Moderator: Jacques Fellay